Platelet-Rich Plasma: Review of Current Literature on its Use for Tendon and Ligament Pathology

Abstract

Purpose of review

Platelet-rich plasma (PRP) contains numerous growth factors and cytokines that potentially offer an alternative treatment modality to assist in the healing of multiple musculoskeletal issues. The purpose of this review was to examine the latest literature on the use of PRP for various ligament and tendon pathologies.

Recent findings

Recent literature has shown moderate- to high-quality evidence that PRP can have positive clinical effects in certain conditions such as lateral epicondylitis and rotator cuff tendinopathy. Prospective studies have shown that it can also be useful in the treatment of patella tendinopathy.

Summary

In summary, we found PRP to have variable success in ligament and tendon pathology; however, it should be considered a viable option in chronic musculoskeletal disease that has failed other treatments. Patient selection, duration of symptoms, and combining with other modalities such as physical therapy should all be taken into consideration in treatment with PRP.

This is a preview of subscription content, access via your institution.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.

    DelRossi AJ, Cernaianu AC, Vertrees RA, et al. Platelet-rich plasma reduces postoperative blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1990;100(2):281–6.

    CAS  PubMed  Google Scholar 

  2. 2.

    Ferrari M, Zia S, Valbonesi M, Henriquet F, Venere G, Spagnolo S, et al. A new technique for hemodilution, preparation of autologous platelet-rich plasma and intraoperative blood salvage in cardiac surgery. Int J Artif Organs. 1987;10(1):47–50.

    CAS  Article  Google Scholar 

  3. 3.

    Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol En-dod. 1998;85(6):638–46.

    CAS  Article  Google Scholar 

  4. 4.

    Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants. 1999;14(4):529–35.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Nguyen RT, Borg-Stein J, McInnis K. Applications of platelet-rich plasma in musculoskeletal and sports medicine: an evidence-based approach. PM R. 2011;3(3):226–50.

    Article  PubMed  PubMed Central  Google Scholar 

  6. 6.

    Mazzocca AD, McCarthy MB, Chowaniec DM, et al. Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am. 2012;94:308–16.

    Article  PubMed  PubMed Central  Google Scholar 

  7. 7.

    Cheung EV, Silverio L, Sperling JW. Strategies in biologic augmentation of rotator cuff repair: a review. Clin Orthop Relat Res. 2010;468:1476–148.

    Article  PubMed  PubMed Central  Google Scholar 

  8. 8.

    Malanga GA, Goldin M. PRP: review of the current evidence of the current evidence of musculoskeletal conditions. Curr Phys Med Rehab. 2014;2(1):1–15.

    Article  Google Scholar 

  9. 9.

    Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009;37:2259–72.

    Article  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Boswell SG, Cole BJ, Sundman EA, Karas V, Fortier LA. Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy. 2012;28:429–39.

    Article  Google Scholar 

  11. 11.

    Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16:585–601.

    Article  Google Scholar 

  12. 12.

    Scherer SS, Tobalem M, Vigato E, et al. Nonactivated versus thrombin-activated platelets on wound healing and fibroblast-myofibroblast differentiation in vivo and in vitro. Plas Reconstr Surg. 2012;129(1):46e–54e.

    Article  CAS  Google Scholar 

  13. 13.

    Geaney LE, Arciero RA, DeBarradino TM, Mazzocca AD. The effects of platelet-rich plasma on tendon and ligament: basic science and clinical application. Oper Tech Sports Med. 2011;19(3):160–4.

    Article  Google Scholar 

  14. 14.

    Anitua E, Andia I, Sanchez M, et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res. 2005;23:281–6.

    CAS  Article  Google Scholar 

  15. 15.

    Zhou Y, Wang J. PRP treatment efficacy for tendinopathy: a review of basic science studies. Biomed Res Int. 2016;2016:1–8. https://doi.org/10.1155/2016/9103792.

    CAS  Article  Google Scholar 

  16. 16.

    Zhang J, Wang JH. Platelet-rich plasma releasate promotes differentiation of tendon stem cells into active tenocytes. AJSM. 2010;38(12):2477–86.

    Google Scholar 

  17. 17.

    Chen L, Dong SW, Tao X, Liu JP, Tang KL, Xu JZ. Autologous platelet-rich clot releasate stimulates proliferation and inhibits differentiation of adult rat tendon stem cells towards nontenocyte lineages. J Int Med Res. 2012;40(4):1399–409.

    CAS  Article  Google Scholar 

  18. 18.

    McCarrel T, Fortier L. Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. J Orthop Res. 2009;27(8):1033–42.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  19. 19.

    Intravia J, Allen DA, Durant TJS, et al. In vitro evaluation of the anti-bacterial effect of two preparations of platelet rich plasma compared with cefazolin and whole blood. Muscles, Ligaments, and Tendon Journal. 2014;4(1):79–84.

    Google Scholar 

  20. 20.

    Madry H, Kohn D, Cucchiarini M. Direct FGF-2 gene transfer via recombinant adeno-associated virus vectors stimulates cell proliferation, collagen production, and the repair of experimental lesions in the human ACL. Am J Sports Med. 2013;41:194–202.

    Article  PubMed  PubMed Central  Google Scholar 

  21. 21.

    Marui T, Niyibizi C, Georgescu HI, Cao M, Kavalkovich KW, Levine RE, et al. Effect of growth factors on matrix synthesis by ligament fibroblasts. J Orthop Res. 1997;15:18–23.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Hildebrand KA, Woo SL-Y, Smith DW, Allen CR, Deie M, Taylor BJ, et al. The effects of platelet derived growth factor-BB on healing of the rabbit medial collateral ligament: an in vivo study. Am J Sports Med. 1998;26:549–54.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  23. 23.

    Batten ML, Hansen JC, Dahners LE, et al. Influence of dosage and timing of application of platelet derived growth factor on early healing of the rat medial collateral ligament. J Orthop Res. 1996;14:736–41.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  24. 24.

    Fleming BC, Spindler KP, Palmer MP, Magarian EM, Murray MM. Collagen-platelet composites improve the biomechanical properties of healing anterior cruciate ligament grafts in a porcine model. Am J Sports Med. 2009;37:1554–63.

    Article  PubMed  PubMed Central  Google Scholar 

  25. 25.

    Hak A, Rajaratnam K, Ayeni OR, Moro J, Peterson D, Sprague S, et al. A double-blinded placebo randomized controlled trial evaluating short-term efficacy of platelet-rich plasma in reducing postoperative pain after arthroscopic rotator cuff repair: a pilot study. Sports Health. 2015;7(1):58–66.

    Article  PubMed  PubMed Central  Google Scholar 

  26. 26.

    Zhao JG, Zhao L, Jiang YX, Wang ZL, Wang J, Zhang P. Platelet-rich plasma in arthroscopic rotator cuff repair: a meta- analysis of randomized controlled trials. Arthroscopy. 2015 Jan;31(1):125–35.

    Article  Google Scholar 

  27. 27.

    • Hurley ET, Lim Fat D, Moran CJ, Mullett H. The efficacy of platelet-rich plasma and platelet-rich fibrin in arthroscopic rotator cuff repair: a meta-analysis of randomized controlled trials. Am J Sports Med. 2018; https://doi.org/10.1177/03635465177513997. This metanalysis encompassed over 18 randomized controlled trials with over 1147 patients and was recently published this year. Their findings found significant improvement with pain and healing after rotator cuff repair using PRP.

  28. 28.

    Verhaegen F, Brys P, Debeer P. Rotator cuff healing after needling of calcific deposit using platelet-rich plasma augmentation: a randomized, prospective clinical trial. J Shoulder Elb Surg. 2016;25(2):169–73.

    Article  Google Scholar 

  29. 29.

    Carr A, Murphy R, Dakin S, Rombach I, et al. Platelet-rich plasma injection with arthroscopic acriomioplasty for chronic rotator cuff tendinopathy. Am J Sports Med. 2015;43(12):2891–7.

    Article  Google Scholar 

  30. 30.

    Rha DW, Park GY, Kim YK, Kim MT, Lee SC. Comparison of the therapeutic effects of ultrasound-guided platelet-rich plasma injection and dry needling in rotator cuff disease: a randomized controlled trial. Clin Rehab. 2013;27(2):113–22.

    Article  Google Scholar 

  31. 31.

    Shams A, El-Sayed M, Gamal O, Ewes W. Subacromial injection of autologous platelet-rich plasma versus corticosteroid for the treatment of symptomatic partial rotator cuff tears. Eur J Orthop Surg Traumatol. 2016;26(8):837–42.

    Article  Google Scholar 

  32. 32.

    Liddle AD, Rodríguez-Merchán C. Platelet-rich plasma in the treatment of patellar tendinopathy: a systematic review. Am J Sports Med. 2015;Oct: 43(10):2583–90.

    Article  Google Scholar 

  33. 33.

    Gosens T, Den Oudsten BL, et al. Pain and activity levels before and after platelet-rich plasma injection treatment of patellar tendinopathy: a prospective cohort study and the influence of previous treatments. Int Orthop. 2012;36(9):1941–6.

    Article  PubMed  PubMed Central  Google Scholar 

  34. 34.

    Zayni R, Thaunat M, Fayard JM, et al. Platelet-rich plasma as a treatment for chronic patellar tendinopathy: comparison of a single versus two consecutive injections. Muscles Ligaments Tendons J. 2015;5(2):92–8.

    PubMed  PubMed Central  Google Scholar 

  35. 35.

    Abate M, Di Carlo L, Verna S, Di Gregorio P, Schiavone C, Salini V. Synergistic activity of platelet rich plasma and high volume image guided injection for patellar tendinopathy. Knee Surg Sports Traumatol Arthrosc. 2018; https://doi.org/10.1007/s00167-018-4930-6.

  36. 36.

    Filardo G, Kon E, Della Villa S, Vincentelli F, Fornasari PM, Marcacci M. Use of platelet-rich plasma for the treatment of refractory jumper’s knee. Int Orthop. 2010;34(6):909–15.

    Article  Google Scholar 

  37. 37.

    Kaux JF, Bruyere O, Croisier JL, Forthomme B, Leo Goff C, Crielaard JM. One-year follow-up of plate-rich plasma infiltration to treat chronic proximal patellar tendinopathies. Acta Orthop Belg. 2015;81(2):251–6.

    PubMed  PubMed Central  Google Scholar 

  38. 38.

    • Andriolo L, Sante Altamura SA, et al. Nonsurgical treatments of patellar tendinopathy: multiple injections of platelet-rich plasma are a suitable option: a systematic review and meta-analysis. Am J Sports Med. 2018;363546518759674 https://doi.org/10.1177/0363546518759674. They conducted a systematic analysis in 2017 and found PRP to be a suitable option for chronic tendinopathy and also demonstrated that number of injections along with incorporation of physical therapy were important in treatment.

  39. 39.

    Cervellin M, de Girolamo L, Bait C, Denti M, Volpi P. Autologous platelet-rich plasma gel to reduce donor-site morbidity after patellar tendon graft harvesting for anterior cruciate ligament reconstruction: a randomized, controlled clinical study. Knee Surg Sports Traumatol Arthrosc. 2012;20(1):114–20.

    CAS  Article  Google Scholar 

  40. 40.

    Walters BL, Porter DA, Hobart SJ, Bedford BB, Hogan DE, McHugh MM, et al. Effect of intraoperative platelet-rich plasma treatment on postoperative donor site knee pain in patellar tendon autograft anterior cruciate ligament reconstruction: a double-blind randomized controlled trial. AJSM. 2018;46(8):1827–35.

    Google Scholar 

  41. 41.

    Dayton P. Anatomic, vascular, and mechanical overview of the Achilles tendon. Clin Podiatr Med Surg. 2017;34(2):107–13.

    Article  Google Scholar 

  42. 42.

    Benjamin M, Toumi H, Ralphs JR, Bydder G, Best TM, Milz S. Where tendons and ligaments meet bone: attachment sites (‘entheses’) in relation to exercise and/or mechanical load. J Anat. 2006;208(4):471–90.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  43. 43.

    Di Matteo B, Kon GFE. Platelet-rich plasma: evidence for the treatment of patellar and Achilles tendinopathy — a systematic review. Musculoskelet Surg. 2015;99(1):1–9.

    Article  Google Scholar 

  44. 44.

    de Vos RJ, Weir A, van Schie HT, Bierma-Zeinstra SM, Verhaar JA, Weinans H, et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA. 2010;303(2):144–9.

    Article  Google Scholar 

  45. 45.

    Boesen AP, Hansen R, Boesen MI, Malliaras P, Langberg H. Effect of high-volume injection , platelet- rich plasma, and sham treatment in chronic midportion Achilles tendinopathy. Am. J. Sports Med. 2017;45(9):2034–43.

    Article  Google Scholar 

  46. 46.

    Brummel J, Baker CL, Hopkins R, Baker CL. Epicondylitis: lateral. Sports Med Arthrosc Rev. 2014 Sep;22(3):e1–6.

    Article  Google Scholar 

  47. 47.

    Ahmad Z, Siddiqui N, Malik SS, Abdus-Samee M, Tytherleigh-Strong G, Rushton N. Lateral epicondylitis: a review of pathology and management. Bone Jt J. 2013 Sep;95-B(9):1158–64.

    CAS  Article  Google Scholar 

  48. 48.

    Chen X, Jones IA, Park C, Vangsness CT. The efficacy of platelet-rich plasma on tendon and ligament healing: a systematic review and meta-analysis with bias assessment. Am J Sports Med. 2018 Jul;46(8):2020–32.

    Article  PubMed  PubMed Central  Google Scholar 

  49. 49.

    • Mi B, Liu G, Zhou W, Lv H, Liu Y, Wu Q, et al. Platelet rich plasma versus steroid on lateral epicondylitis: meta-analysis of randomized clinical trials. Phys Sports Med. 2017;45(2):97–104. This study was important because it examined eight randomized controlled trials involving over 511 patients. Their study revealed that cortisone injection was helpful in the short-term, as opposed to PRP which was much more effective in long-term patient outcomes.

    Google Scholar 

  50. 50.

    Ben-Nafa W, Munro W. The effect of corticosteroid versus platelet-rich plasma injection therapies for the management of lateral epicondylitis: a systematic review. SICOT-J. 2018;4:11.

    Article  PubMed  PubMed Central  Google Scholar 

  51. 51.

    • Mishra AK, Skrepnik NV, Edwards SG, Jones GL, Sampson S, Vermillion DA, et al. Efficacy of platelet-rich plasma for chronic tennis elbow: a double-blind, prospective, multicenter, randomized controlled trial of 230 patients. Am J Sports Med. 2014;42(2):463–71. In this study, the authors performed a double-blinded randomized control trial involving over 230 patients and further proved that patients treated with leukocyte-enriched PRP was more effective than the control group.

    Article  PubMed  PubMed Central  Google Scholar 

  52. 52.

    Merolla G, Dellabiancia F, Ricci A, Mussoni MP, Nucci S, Zanoli G, et al. Arthroscopic debridement versus platelet-rich plasma injection: a prospective, randomized, comparative study of chronic lateral epicondylitis with a nearly 2-year follow-up. Arthrosc J Arthrosc Relat Surg. 2017 Jul;33(7):1320–9.

    Article  Google Scholar 

  53. 53.

    Park SK, Choic YK, Kim HJ. Hypopigmentation and subcutaneous fat, muscle, atrophy after local corticosteroid injection. Korean J Anesthesiol. 2013;65(6):59–61.

    Article  Google Scholar 

  54. 54.

    Clark NJ, Desai VS, Dines JD, Morrey ME, Camp CL. Nonreconstruction options for treating medial ulnar collateral ligament injuries of the elbow in overhead athletes. Curr Rev Musculoskelet Med. 2018 Mar;11(1):48–54.

    Article  PubMed  PubMed Central  Google Scholar 

  55. 55.

    Podesta L, Crow SA, Volkmer D, Bert T, Yocum LA. Treatment of partial ulnar collateral ligament tears in the elbow with platelet-rich plasma. Am J Sports Med. 2013;41(7):1689–94.

    Article  Google Scholar 

  56. 56.

    Hoffman JK, Protzman NM, Malhotra AD. Biologic augmentation of the ulnar collateral ligament in the elbow of a professional baseball pitcher. Case Rep Orthop. 2015;2015:130157.

    PubMed  PubMed Central  Google Scholar 

  57. 57.

    Dines JS, Wiliams PN, ElAttrache N, Conte S, Ahmad CS, et al. Platelet-rich plasma can be used to successfully treat elbow ulnar collateral ligament insufficency in high-level throwers. Am J Orthop. 2016;45(5):296–300.

    PubMed  Google Scholar 

  58. 58.

    Deal JB, Smith E, Heard W, O'Brien MJ, Savoie FH. Platelet-rich plasma for primary treatment of partial ulnar collateral ligament tears: MRI correlation with results. Orthop J Sports Med. 2017;5(11):2325967117738238.

    Article  PubMed  PubMed Central  Google Scholar 

  59. 59.

    Figueroa D, Figueroa F, Calvo R, Vaisman A, Ahumada X, Arellano S. Platelet-rich plasma use in anterior cruciate ligament surgery: systematic review of the literature. J of Arth and Rel Surg. 2015;31(5):981–8.

    Article  Google Scholar 

  60. 60.

    Mirzatolooei F, Alamdari MT, Khalkhali HR. The impact of platelet-rich plasma on the prevention of tunnel widening in anterior cruciate ligament reconstruction using quadrupled autologous hamstring tendon: a randomized clinical trial. Bone Joint J. 2013;95-B(1):65–9.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  61. 61.

    Vadala A, Iorio R, De Carli A, et al. Platelet-rich plasma: does it help reduce tunnel widening after ACL reconstruction? Knee Surg Sports Traumatol Arthrosc. 2013;21(4):824–9.

    Article  Google Scholar 

  62. 62.

    Rupreht M, Vogrin M, Hussein M. MRI evaluation of tibial tunnel wall cortical bone formation after platelet-rich plasma applied during anterior cruciate ligament reconstruction. Radiol Oncol. 2013;47(2):118–24.

    Article  Google Scholar 

  63. 63.

    Vogrin M, Rupreht M, Crnjac A, Dinevski D, Krajnc Z, Recnik G. The effect of platelet-derived growth factors on knee stability after anterior cruciate ligament reconstruction: a prospective randomized clinical study. Wien Klin Wochenschrift. 2010;122(S2):91–5.

    CAS  Article  Google Scholar 

  64. 64.

    Magnussen RA, Flanigan DC, Pedroza AD, Heinlein KA, Kaeding CC. Platelet rich plasma use in allograft ACL reconstructions: two-year clinical results of a MOON cohort study. Knee. 2013;20(4):277–80. https://doi.org/10.1016/j.knee.2012.12.001.

    Article  PubMed  PubMed Central  Google Scholar 

  65. 65.

    Di Matteo B, Loibl M, Andriolo L, et al. Biologic agents for anterior cruciate ligament healing: a systematic review. World J of Orthop. 2016;7(9):592–603.

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Cameron Kia.

Ethics declarations

Conflict of interest

Dr. Mazzocca is a consultant for Arthrex, Inc. and has received financial support from the biomechanics lab. All other authors declare no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Protein-Rich Plasma: From Bench to Treatment of Arthritis

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kia, C., Baldino, J., Bell, R. et al. Platelet-Rich Plasma: Review of Current Literature on its Use for Tendon and Ligament Pathology. Curr Rev Musculoskelet Med 11, 566–572 (2018). https://doi.org/10.1007/s12178-018-9515-y

Download citation

Keywords

  • Platelet-rich plasma
  • PRP
  • Tendinopathy
  • Ligament
  • Biologics